NDIS Pricing changes discriminate against rural and remote Australians

Changes to provider travel arrangements will have a disproportionate impact on participants living in rural communities, contradicting the findings of the NDIS Review (2023) that identified "...continuing issues in accessing allied health supports in regional and rural parts of Australia. Over 33 per cent of participants — who have been in the scheme for at least one year — are not accessing any therapy supports in small and medium rural towns, despite having funding for these supports" (page 180).

SARRAH members based in central Queensland, northern Queenland, central west NSW, southern NSW, Victoria and South Australia are all indicating that the new travel pricing arrangements may lead to withdrawal of services to small communities in MMM 4-7 locations, where alternative providers do not exist. Other providers have placed restrictions on travel, to the detriment of NDIS participants when best practice supports delivery in participants’ natural environment.

Going forward, clinicians may be placed in the untenable position of declining therapy supports to participants whose location or mobility challenges make clinic-based service delivery difficult.  Not only does this limit NDIS participants' choice and control, but it is also discriminatory. That it’s allied health professionals, and not the decision-makers, who have been placed in the position of explaining the impact of these pricing changes to participants is especially egregious.

The NDIS Review recommended the NDIA should progressively roll out provider panel arrangements for allied health supports in small and medium rural towns or where participants face persistent supply gaps (Action 13.2, page 184).  To our members' knowledge, these arrangements are yet to be implemented.  It is therefore premature, and potentially harmful to NDIS participants, to introduce new travel provider arrangements without contingencies in place to manage the needs of those clients who are at risk of losing access to therapy supports after 1 July 2025.

SARRAH has called on Senator McAllister and the NDIA to:

  • Delay implementing the new pricing schedule;

  • Undertake a formal review of the potential impact of travel pricing arrangements that includes genuine engagement with providers operating in MMM 4 - 7 locations; and

  • Provide an update on actions taken in response to the NDIS Review completed in December 2023.

We have also requested meetings with The Hon. Emma McBride MP, Assistant Minister for Rural and Regional Health, and the Chief Allied Health Officer, to raise our concerns and seek their advocacy in support of rural and remote Australians.

Call to Action:

You can play a part, by writing to your local Member of Parliament to raise awareness of the likely impact these pricing arrangements will have on rural and remote communities. You can download the template and use this as a basis for your letter.

If you have an opportunity to meet with your local Member, even better.

Please get in touch with us (sarrah@sarrah.org.au) if you need further information or assitance to identify your local member.

NDIS Pricing Arrangements .docx